Who is sponsoring NCT00442091?

NCT00442091 is sponsored by Odense University Hospital.

What drugs are being tested in NCT00442091?

Interventions in NCT00442091: dandelion juice.

What condition does NCT00442091 study?

NCT00442091 studies Vesicular Palmoplantar Eczema, Pompholyx.

Is NCT00442091 still recruiting?

NCT00442091 is currently completed. Last updated 2 March 2020.

Last reviewed 2020-03-02 · How we verify

NCT00442091

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Dandelion Juice in the Treatment of Dyshidrotic Hand Eczema

Completed NA Last updated 2 March 2020

What this trial tests

NA trial testing dandelion juice in Vesicular Palmoplantar Eczema in 4 participants. Completed in 1 December 2019.

Timeline

1 December 2010

Primary endpoint
1 December 2019

1 December 2019

Quick facts

Lead sponsor	Odense University Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	4
Start date	1 December 2010
Primary completion	1 December 2019
Estimated completion	1 December 2019
Sites	1 location across Denmark

Drugs / interventions tested

dandelion juice — full drug profile →

Conditions studied

Vesicular Palmoplantar Eczema — all drugs for Vesicular Palmoplantar Eczema →
Pompholyx — all drugs for Pompholyx →

Sponsor

Odense University Hospital

Who can join

18 and older, any sex, with Vesicular Palmoplantar Eczema or Pompholyx. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Improvement in dyshidrotic hand eczema in the study period assessed by HECSI score.
Time frame: 3-4 weeks

Sponsor's own description

Dandelion juice has been used in herbal medicine for at least 1000 years. Vesicular hand eczema is a rare, but difficult to treat, type of hand eczema. One case report has shown that ingestion of dandelion juice could induce a beneficial effect on this type of eczema. The purpose of this study is to test whether this effect can be retrieved in other patients.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Dandelion (<i>Taraxacum</i> Genus): A Review of Chemical Constituents and Pharmacological Effects.
Fan M, Zhang X, Song H, Zhang Y. · · 2023 · cited 62× · PMID 37446683 · DOI 10.3390/molecules28135022
<i>Taraxacum mongolicum</i> Ameliorates DNCB-Induced Atopic Dermatitis-like Symptoms in Mice by Regulating Oxidative Stress, Inflammation, MAPK, and JAK/STAT/TSLP Signaling Pathways.
Jiang WP, Hung HP, Lin JG, Chang LH, et al · · 2025 · cited 1× · PMID 40724851 · DOI 10.3390/ijms26146601
Antimicrobial and Anti-Infective Potential of Herbal Creams in Dermatology: Efficacy, Safety, and Challenges in Skin Infection Management.
Brar GS, Nandy SK, Sharma A, Siddiqui AJ, et al · · 2025 · PMID 41362433 · DOI 10.2147/idr.s565852

Verify or expand the search:

Other Odense University Hospital trials

Trials by the same sponsor.

NCT07163091 — Bracing After Ankle Fracture · NA · not yet recruiting
NCT07521696 — Physical Recovery During Bracing After Ankle Fracture (Re-BAF) · NA · not yet recruiting
NCT07466212 — QoLIDia: Quality of Life in Cancer Patients With Diabetes During Immunotherapy · not yet recruiting
NCT07191379 — Self-administered Subcutaneous Daratumumab in Patients With Multiple Myeloma · Phase 4 · not yet recruiting
NCT07170085 — Positioning of Children With Acute Respiratory Insufficiency · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00442091 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Odense University Hospital
Last refreshed: 2 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00442091.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing